Aurinia Pharmaceuticals Overview

  • Founded
  • 1993
Founded
  • Status
  • Public
  • Employees
  • 62
Employees
  • Stock Symbol
  • AUP
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $13.47
  • (As of Thursday Closing)

Aurinia Pharmaceuticals General Information

Description

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and Dry Eye Syndrome (DES). Geographically, it derives maximum revenue from the United States followed by China.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Stock Exchange
TSE
Primary Office
  • 4464 Markham Street
  • Suite 1203
  • Victoria, British Columbia V8Z 7X8
  • Canada
+1 (250) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Aurinia Pharmaceuticals Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$13.47 $13.15 $3.52 - $21.86 $1.7B 126M 225K -$1.31

Aurinia Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 1,537,307 2,060,991 442,590 200,162
Revenue 318 318 463 418
EBITDA (142,194) (124,817) (64,716) (70,376)
Net Income (141,577) (123,846) (64,120) (70,792)
Total Assets 295,278 326,683 145,863 189,847
Total Debt 22,451 29,353 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Aurinia Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Aurinia Pharmaceuticals‘s full profile, request access.

Request a free trial

Aurinia Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious dis
Biotechnology
Victoria, Canada
62 As of 2019
00000
0000 0000-00-00
00000000 00000

00000000

or sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna
0000000000000
Charlottesville, VA
00 As of 0000
000.00
00000000 000.00

0000000

consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut
0000000000000
Hayward, CA
00 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aurinia Pharmaceuticals Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Diffusion Pharmaceuticals Formerly VC-backed Charlottesville, VA 00 000.00 00000000 000.00
0000000 0000000000 Corporation Hayward, CA 00 00000 00000000 00000
0000000 0000000000 Formerly VC-backed Cambridge, MA 000 00000 000000000 00000
000000 Formerly VC-backed Vedbæk, Denmark 000 00000 000000&0 00000
To view Aurinia Pharmaceuticals’s complete competitors history, request access »

Aurinia Pharmaceuticals Executive Team (14)

Name Title Board Seat Contact Info
Peter Greenleaf Chief Executive Officer & Board Member
Dennis Bourgeault Chief Financial Officer, Finance
Michael Martin Chief Operating Officer, Operations
Stephanie Gillis-Paulgaard Director, Corporate Communications
AJ Simon Director, Information Technology
You’re viewing 5 of 14 executive team members. Get the full list »

Aurinia Pharmaceuticals Board Members (17)

Name Representing Role Since
00000000 00000000 00.0 Lumira Ventures Board Member 000 0000
000000 000000 00.0 Aurinia Pharmaceuticals Board Member 000 0000
00000 00000 00 Aurinia Pharmaceuticals Board Member 000 0000
000000 00000 00.0 Self Chairman of the Board, Member of Audit Committee and Nominating and Corporate Governance Committee 000 0000
000000 000000-0000 00 Aurinia Pharmaceuticals Board Member, Chairman of Nominating and Corporate Governance Committee & Member of Compensation Committee 000 0000
You’re viewing 5 of 17 board members. Get the full list »

Aurinia Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aurinia Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Aurinia Pharmaceuticals‘s full profile, request access.

Request a free trial

Aurinia Pharmaceuticals Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000000 000000 23-Sep-2013 000000000000000000 Biotechnology
To view Aurinia Pharmaceuticals’s complete acquisitions history, request access »